Clinical trial
Early Manifest Glaucoma Trial (EMGT)
NCT00000132 · National Eye Institute (NEI), NIH · Unknown status
Key facts
| NCT number | NCT00000132 |
|---|---|
| Title | Early Manifest Glaucoma Trial (EMGT) |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Open-Angle Glaucoma |
| Intervention type | Drug, Procedure |
| Interventions | Betaxolol, Argon Laser Trabeculoplasty |
| Start date | Oct 1, 1992 |
| First posted | Sep 24, 1999 |
| Last update posted | Jun 24, 2005 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: